Ilimaquinone Induces Apoptosis and Autophagy in Human Oral Squamous Cell Carcinoma Cells

Cheng-Wen Lin1,2, Li-Yuan Bai3,4, Jui-Hsin Su5

  • 1Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 40402, Taiwan.

Biomedicines
|August 23, 2020
PubMed

Insights

Ilimaquinone (IQ), a marine sponge compound, effectively reduced oral squamous cell carcinoma (OSCC) cell viability. IQ triggers apoptosis and protective autophagy, showing potential for OSCC cancer therapy.

Area of Science:

  • Marine Natural Products
  • Cancer Biology
  • Pharmacology

Background:

  • Oral squamous cell carcinoma (OSCC) is a significant global health concern.
  • Marine natural products offer a promising source for novel anti-cancer agents.
  • Ilimaquinone (IQ) is a sesquiterpene quinone isolated from the marine sponge *Halichondria* sp.

Purpose of the Study:

  • To investigate the anti-tumor activity of ilimaquinone (IQ) in oral squamous cell carcinoma (OSCC) cells.
  • To elucidate the mechanisms underlying IQ's anti-cancer effects, including apoptosis and autophagy induction.

Main Methods:

  • Cell viability assays (IC50 determination) on OSCC cell lines (SCC4, SCC2095).
  • Flow cytometry to analyze apoptosis and reactive oxygen species (ROS) generation.
  • Western blotting to assess protein expression (Akt, p38, Mcl-1, p53, LC3B-II, Atg5).
  • Gene knockdown (p53) and use of autophagy inhibitors (3-methyladenine, chloroquine).

Main Results:

  • IQ significantly suppressed OSCC cell viability with IC50 values of 7.5 μM (SCC4) and 8.5 μM (SCC2095).
  • IQ induced caspase-dependent apoptosis and modulated key cell growth regulators (Akt, p38, Mcl-1, p53).
  • IQ triggered ROS generation and protective autophagy, evidenced by organelle changes and protein expression.

Conclusions:

  • Ilimaquinone exhibits potent anti-tumor activity against OSCC cells.
  • IQ's mechanism involves inducing apoptosis and protective autophagy, modulated by p53 and ROS.
  • IQ demonstrates potential as a therapeutic agent for oral squamous cell carcinoma.